Frank Xiao‐Feng Qin

Frank Xiao‐Feng Qin

Auto-generated profile, based on publicly available information

Frank Xiao‐Feng Qin

Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College; Suzhou Institute of Systems Medicine, Suzhou, China

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZCZiyi Chen
Ziyi Chen
AHAnfei Huang
Anfei Huang
JSJiya Sun
Jiya Sun
TJTaijiao Jiang
Taijiao Jiang
FQF. Xiao-Feng Qin
F. Xiao-Feng Qin
AWAiping Wu
Aiping Wu
Mice are some of the widely used experimental animal models for studying human diseases. Defining the compositions of immune cell populations in various tissues from experimental mouse models is critical to understanding the involvement of immune responses in various physiological and patho-physiological conditions. However, non-lymphoid tissues are normally composed of vast and diverse cellular components, which make it difficult to quantify the relative proportions of immune cell types. Here we report the development of a computational algorithm, ImmuCC, to infer the relative compositions of 25 immune cell types in mouse tissues using microarray-based mRNA expression data. The ImmuCC algorithm showed good performance and robustness in many simulated datasets. Remarkable concordances were observed when ImmuCC was used on three public datasets, one including enriched immune cells, one with normal single positive T cells, and one with leukemia cell samples. To validate the performance of ImmuCC objectively, thorough cross-comparison of ImmuCC predicted compositions and flow cytometry results was done with in-house generated datasets collected from four distinct mouse lymphoid tissues and three different types of tumor tissues. The good correlation and biologically meaningful results demonstrate the broad utility of ImmuCC for assessing immune cell composition in diverse mouse tissues under various conditions.

5 June 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZCZiyi Chen
Ziyi Chen
LQLijun Quan
Lijun Quan
AHAnfei Huang
Anfei Huang
QZQiang Zhao
Qiang Zhao
YYYao Yuan
Yao Yuan
AWAiping Wu
Aiping Wu
The RNA sequencing approach has been broadly used to provide gene-, pathway-, and network-centric analyses for various cell and tissue samples. However, thus far, rich cellular information carried in tissue samples has not been thoroughly characterized from RNA-Seq data. Therefore, it would expand our horizons to better understand the biological processes of the body by incorporating a cell-centric view of tissue transcriptome. Here, a computational model named seq-ImmuCC was developed to infer the relative proportions of 10 major immune cells in mouse tissues from RNA-Seq data. The performance of seq-ImmuCC was evaluated among multiple computational algorithms, transcriptional platforms, and simulated and experimental datasets. The test results showed its stable performance and superb consistency with experimental observations under different conditions. With seq-ImmuCC, we generated the comprehensive landscape of immune cell compositions in 27 normal mouse tissues and extracted the distinct signatures of immune cell proportion among various tissue types. Furthermore, we quantitatively characterized and compared 18 different types of mouse tumor tissues of distinct cell origins with their immune cell compositions, which provided a comprehensive and informative measurement for the immune microenvironment inside tumor tissues. The online server of seq-ImmuCC are freely available at http://wap-lab.org:3200/immune/.

10 February 2022 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
XDXiaohong Du
Xiaohong Du
HTHaijun Tang
Haijun Tang
LGLong Gao
Long Gao
ZWZhao Wu
Zhao Wu
FMFang Meng
Fang Meng
FQF. Xiao-Feng Qin
F. Xiao-Feng Qin

1 December 2019 in Cell Reports
Verified
Journal Article
Open access
GTGuangyun Tan
Guangyun Tan
ZYZhaohong Yi
Zhaohong Yi
HSHongxiao Song
Hongxiao Song
FXFengchao Xu
Fengchao Xu
FLFeng Li
Feng Li
GCGenhong Cheng
Genhong Cheng
To understand the molecular mechanisms that mediate the anti-hepatitis B virus (HBV) effect of interferon (IFN) therapy, we conduct high-throughput bimolecular fluorescence complementation screening to identify potential physical interactions between the HBx protein and 145 IFN-stimulated genes (ISGs). Seven HBx-interacting ISGs have consistent and significant inhibitory effects on HBV replication, among which TRIM5γ suppresses HBV replication by promoting K48-linked ubiquitination and degradation of the HBx protein on the K95 ubiquitin site. The B-Box domain of TRIM5γ under overexpression conditions is sufficient to trigger HBx degradation and is responsible both for interacting with HBx and recruiting TRIM31, which is an ubiquitin ligase that triggers HBx ubiquitination. High expression levels of TRIM5γ in IFN-α-treated HBV patients might indicate a better therapeutic effect. Thus, our studies identify a crucial role for TRIM5γ and TRIM31 in promoting HBx degradation, which may facilitate the development of therapeutic agents for the treatment of patients with IFN-resistant HBV infection.

4 May 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
QLQingxiang Liu
Qingxiang Liu
YWYaoxing Wu
Yaoxing Wu
YQYunfei Qin
Yunfei Qin
JHJiajia Hu
Jiajia Hu
WXWeihong Xie
Weihong Xie
JCJun Cui
Jun Cui
Deubiquitinase family proteins are broadly involved in modulating antiviral response through dynamic and diverse mechanisms.

26 February 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
XWXiangwei Wu
Xiangwei Wu
JWJingfeng Wang
Jingfeng Wang
SWShanshan Wang
Shanshan Wang
FWFei Wu
Fei Wu
ZCZhigao Chen
Zhigao Chen
FQF. Xiao-Feng Qin
F. Xiao-Feng Qin
Influenza A virus (IAV) is a worldwide ongoing health threat causing diseases in both humans and animals. The interaction between IAV and host is a dynamic and evolving process that influences the pathogenicity and host specificity of the virus. TRIM14, a member of tripartite motif (TRIM) family, has been demonstrated to possess a strong capability of regulating type I interferon and NF-κB induction in host defense against viral infection. In this study, we found that TRIM14 could restrict the replication of IAV in a type I interferon and NF-κB independent manner. Mechanistically, different domains of TRIM14 could selectively interact with the viral nucleoprotein (NP), resulting in disparate influences on the RNP formation and viral replication. In particular, the PRYSPRY domain of TRIM14 exhibited a potent inhibitory activity on NP protein stability and IAV replication. On the contrary, the ΔS2 domain could rather antagonize the function of PRYSPRY domain and promote the IAV RNP formation by stabilizing NP. At the biochemical level, TRIM14-NP interaction could induce the K48-linked ubiquitination and proteasomal degradation of NP. Moreover, due to the rapid degradation of newly synthesized NP, TRIM14 could effectively block the translocation of NP from cytoplasm to nucleus thus further restrain the propagation of IAV in host cells. Taken together, our study has unraveled a previously unknown mechanism of TRIM14 mediated inhibition on RNP formation and influenza virus replication, and provides a new paradigm of complex and multifaceted host–pathogen interaction between ISG and viral protein.